BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 29595921)

  • 21. Geographical variation in malignant and benign/borderline brain and CNS tumor incidence: a comparison between a high-income and a middle-income country.
    Wanner M; Rohrmann S; Korol D; Shenglia N; Gigineishvili T; Gigineishvili D
    J Neurooncol; 2020 Sep; 149(2):273-282. PubMed ID: 32813185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Descriptive epidemiology of primary brain and CNS tumors: results from the Central Brain Tumor Registry of the United States, 1990-1994.
    Surawicz TS; McCarthy BJ; Kupelian V; Jukich PJ; Bruner JM; Davis FG
    Neuro Oncol; 1999 Jan; 1(1):14-25. PubMed ID: 11554386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of cerebral magnetic resonance imaging in outpatients on observed incidence of intracranial tumors and patient survival: a national observational study.
    Solheim O; Torsteinsen M; Johannesen TB; Jakola AS
    J Neurosurg; 2014 Apr; 120(4):827-32. PubMed ID: 24484230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiology of pediatric primary malignant central nervous system tumors in Iran: a 10 year report of National Cancer Registry.
    Beygi S; Saadat S; Jazayeri SB; Rahimi-Movaghar V
    Cancer Epidemiol; 2013 Aug; 37(4):396-401. PubMed ID: 23562043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of the Benign Brain Tumor Cancer Registries Amendment Act (Public Law 107-260) on non-malignant brain and central nervous system tumor incidence trends.
    McCarthy BJ; Kruchko C; Dolecek TA
    J Registry Manag; 2013; 40(1):32-5. PubMed ID: 23778695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Will primary central nervous system lymphoma be the most frequent brain tumor diagnosed in the year 2000?
    Corn BW; Marcus SM; Topham A; Hauck W; Curran WJ
    Cancer; 1997 Jun; 79(12):2409-13. PubMed ID: 9191531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence and survival trends in oligodendrogliomas and anaplastic oligodendrogliomas in the United States from 2000 to 2013: a CBTRUS Report.
    Achey RL; Khanna V; Ostrom QT; Kruchko C; Barnholtz-Sloan JS
    J Neurooncol; 2017 May; 133(1):17-25. PubMed ID: 28397028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment.
    Edwards BK; Brown ML; Wingo PA; Howe HL; Ward E; Ries LA; Schrag D; Jamison PM; Jemal A; Wu XC; Friedman C; Harlan L; Warren J; Anderson RN; Pickle LW
    J Natl Cancer Inst; 2005 Oct; 97(19):1407-27. PubMed ID: 16204691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Temporal trends in incidence of primary brain tumors in the United States, 1985-1999.
    Hoffman S; Propp JM; McCarthy BJ
    Neuro Oncol; 2006 Jan; 8(1):27-37. PubMed ID: 16443945
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The descriptive epidemiology of craniopharyngioma.
    Bunin GR; Surawicz TS; Witman PA; Preston-Martin S; Davis F; Bruner JM
    J Neurosurg; 1998 Oct; 89(4):547-51. PubMed ID: 9761047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Recent incidences and trends of childhood malignant solid tumors in Shanghai, 2002-2010].
    Bao PP; Li K; Wu CX; Huang ZZ; Wang CF; Xiang YM; Peng P; Gong YM; Xiao XM; Zheng Y
    Zhonghua Er Ke Za Zhi; 2013 Apr; 51(4):288-94. PubMed ID: 23927803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Consistency of primary brain tumor diagnoses and codes in cancer surveillance systems.
    Castillo MS; Davis FG; Surawicz T; Bruner JM; Bigner S; Coons S; Bigner DD
    Neuroepidemiology; 2004; 23(1-2):85-93. PubMed ID: 14739573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Primary cerebral non-Hodgkin's lymphomas and primary malignant brain tumors in a well-defined geographical area. Population-based data from the registry of non-Hodgkin's lymphoma in western Denmark, LYFO and the cancer registry, Kraeftens Bekaempelse].
    Jensen MK; d'Amore FA; Jensen MK; Christensen BE; Thorling K; Pedersen M; Johansen P; Boesen AM; Andersen E
    Ugeskr Laeger; 1996 Jul; 158(31):4406-12. PubMed ID: 8759999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trends in the incidence of primary brain, central nervous system and intracranial tumors in Israel, 1990-2015.
    Keinan-Boker L; Friedman E; Silverman BG
    Cancer Epidemiol; 2018 Oct; 56():6-13. PubMed ID: 30015055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The rationale for standardized registration and reporting of brain and central nervous system tumors in population-based cancer registries.
    Davis FG; Bruner JM; Surawicz TS
    Neuroepidemiology; 1997; 16(6):308-16. PubMed ID: 9430131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Austrian Brain Tumour Registry: a cooperative way to establish a population-based brain tumour registry.
    Wöhrer A; Waldhör T; Heinzl H; Hackl M; Feichtinger J; Gruber-Mösenbacher U; Kiefer A; Maier H; Motz R; Reiner-Concin A; Richling B; Idriceanu C; Scarpatetti M; Sedivy R; Bankl HC; Stiglbauer W; Preusser M; Rössler K; Hainfellner JA
    J Neurooncol; 2009 Dec; 95(3):401-411. PubMed ID: 19562257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Time trends in oligodendroglial and astrocytic tumor incidence.
    McCarthy BJ; Propp JM; Davis FG; Burger PC
    Neuroepidemiology; 2008; 30(1):34-44. PubMed ID: 18259099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Global incidence of brain and spinal tumors by geographic region and income level based on cancer registry data.
    Bell JS; Koffie RM; Rattani A; Dewan MC; Baticulon RE; Qureshi MM; Wahjoepramono EJ; Rosseau G; Park K; Nahed BV
    J Clin Neurosci; 2019 Aug; 66():121-127. PubMed ID: 31133367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pilot test for linking population-based cancer registries with CCG/POG pediatric registries.
    Ross F
    J Ky Med Assoc; 2002 May; 100(5):195-9. PubMed ID: 12040910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Malignant central nervous system tumors among adolescents and young adults (15-39 years old) in 14 Southern-Eastern European registries and the US Surveillance, Epidemiology, and End Results program: Mortality and survival patterns.
    Georgakis MK; Papathoma P; Ryzhov A; Zivkovic-Perisic S; Eser S; Taraszkiewicz Ł; Sekerija M; Žagar T; Antunes L; Zborovskaya A; Bastos J; Florea M; Coza D; Demetriou A; Agius D; Strahinja RM; Themistocleous M; Tolia M; Tzanis S; Alexiou GA; Papanikolaou PG; Nomikos P; Kantzanou M; Dessypris N; Pourtsidis A; Petridou ET
    Cancer; 2017 Nov; 123(22):4458-4471. PubMed ID: 28708937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.